Skip to content

PTHS PTHS Xepi Royalty Agreement — Contractual Obligation

Other product segments

Reedy Creek Purchase Agreement
$20.87M
ZELSUVMI Royalty Agreement
$10.2M
Amended Sato license
$1.13M
Channel Products Royalty Agreement
$0

Similar metrics at other companies

PVL
PVLARoyalty Agreement Liability
$19.8M+50.5%
Scilex Holding Company logo
SCLXScilex Pharma — Royalty Expense
$1.2M+33.3%
Ardelyx logo
ARDXDeferred royalty obligation
$6.5M+1.4%
Aquestive Therapeutics, Inc. logo
AQSTRoyalty obligations, net
$26.91M+24.8%
Abercrombie & Fitch logo
ANFRoyalty — Contract with Customer, Liability, Current
$34.31M+3.8%
Esperion Therapeutics logo
ESPRRoyalty sale liability
$210.43M-11.9%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:ContractualObligation.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's xepi royalty agreement — contractual obligation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's xepi royalty agreement — contractual obligation?
PTHS (PTHS) reported xepi royalty agreement — contractual obligation of $2.28M in Q1 2026.
What does xepi royalty agreement — contractual obligation mean?
The total aggregate liability representing the company's contractual commitment to pay royalties under the Xepi license agreement. This metric captures the full scope of the financial burden associated with the product's commercialization rights.